By Chris Wack Immuron Ltd. shares were up 45% to $2.71 after the company said that the U.S. Naval Medical Research Center has received approval...
By Chris Wack Immuron Ltd. said Monday that the U.S. Naval Medical Research Center has received approval from the U.S. Food and Drug...
By Chris Wack Immuron Ltd. shares were up 40% to $2.26 after the company said Friday that it has received approval from the U.S. Food and Drug...
By Chris Wack Immuron Ltd. said Friday that it has received approval from the U.S. Food and Drug Administration to proceed with the clinical...
By Chris Wack Immuron Ltd. said Tuesday that it has executed a master service agreement with U.S.-based Pharmaron CPC Inc. The biopharmaceutical...
By Connor Hart Immuron Ltd. on Tuesday said the U.S. Naval Medical Research Center received feedback from the U.S. Food and Drug Administration...
By Chris Wack Immuron Ltd. said a new request for $4 million in funding has been considered to be "eligible for award" by the Medical...
By Chris Wack Immuron Ltd. shares were up 40% to $3.66 after the company said it was awarded 4.8 million Australian dollars ($3.4 million) in...
By Chris Wack Immuron Ltd. said it was awarded 4.8 million Australian dollars ($3.4 million) in funding in a new research agreement with the U.S...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads